GLYCOS BIOMEDICAL LTD
6TH FLOOR, 2 LONDON WALL PLACE, LONDON EC2Y 5AU- Active
- Private Limited Company
- Company No. 13399379
- Last Updated: 01 Mar 2024
Company Profile
GLYCOS BIOMEDICAL LTD was incorporated on Friday, May 14, 2021 as a Private Limited Company with registered address in LONDON. GLYCOS BIOMEDICAL LTD has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 3 years 6 months.
| Name | GLYCOS BIOMEDICAL LTD |
|---|---|
| Company number | 13399379 |
| Company type | Private Limited Company |
| Incorporation date | 14 May 2021 |
| Status | Active |
| Industry (SIC 2007) |
Address
| Registered Address |
6TH FLOOR 2 LONDON WALL PLACE LONDON EC2Y 5AU |
|---|---|
| Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
| Name | Nature of Control |
|---|---|
| Muhammad Zubair Ahmad Nationality: American |
Dates: Tuesday, April 11, 2023 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
| Dr Pervinder Singh Bhogal Nationality: British |
Dates: Friday, May 14, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
| Dr Ounali Sherali Jaffer Nationality: British |
Dates: Friday, May 14, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
| Type of accounts | TOTAL EXEMPTION FULL |
|---|---|
| End of financial Year | 31 May |
| Next annual accounts due | 29 May 2024, (-169 days left) |
| Latest accounts | 31 May 2022 |
| Next confirmation statement due | 11 June 2022 |
| Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against GLYCOS BIOMEDICAL LTD.
Previous Names
| Name | Change Date |
|---|---|
| GLYCOS BIOMEDICAL LTD | 14 May 2021 |